Big Gain For Tricida, Inc.
Tue, Nov 16, 2021 at 05:30 PM
Tricida, Inc. (TCDA:NASDAQ) rocketted at $7.97, a gain of 25.5%. On Mon, Nov 15, 2021, TCDA:NASDAQ hit a New 2-Week High of $6.35. The stock appeared on our News Catalysts scanner on Mon, Nov 08, 2021 at 04:31 PM in the 'EARNINGS' category. From Mon, Nov 01, 2021, the stock recorded 80.00% Up Days and 90.91% Green Days
About Tricida, Inc. (TCDA:NASDAQ)
Tricida Inc is a late-stage pharmaceutical company. It is engaged in the development of novel therapeutics to address renal, metabolic and cardiovascular disease. The primary area of focus is to slow the progression of chronic kidney disease through the treatment of metabolic acidosis.
Top 10 Gainers:
- BOQI International Medical Inc. (BIMI:NASDAQ), 54.97%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 48.37%
- PROG (PROG:NASDAQ), 39.48%
- Kezar Life Sciences, Inc. (KZR:NASDAQ), 37.81%
- IONQ (IONQ:NYSE), 33.1%
- PLBY (PLBY:NASDAQ), 31.58%
- Trio-Tech International (TRT:NYSEMKT), 30.31%
- IONM (IONM:NASDAQ), 25.77%
- Tricida, Inc. (TCDA:NASDAQ), 25.51%
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 25.37%